|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
C17.8 |
Malignant neoplasm of overlapping sites of small intestine
|
C178 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 41.97%
|
34.08%
|
11.41%
|
5.77%
|
2.25%
|
1.55%
|
1.13%
|
0.42%
|
0.42%
|
0.42%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C17.8*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
174
|
174
|
|
80053
|
COMPREHEN METABOLIC PANEL |
164
|
164
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
114
|
115
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
99
|
99
|
|
82378
|
CARCINOEMBRYONIC ANTIGEN |
79
|
79
|
|
J9190
|
FLUOROURACIL INJECTION |
47
|
271
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
42
|
46
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
37
|
3,085
|
|
36591
|
DRAW BLOOD OFF VENOUS DEVICE |
36
|
36
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
33
|
33
|
|
J1642
|
INJ HEPARIN SODIUM PER 10 U |
32
|
1,321
|
|
83735
|
ASSAY OF MAGNESIUM |
32
|
32
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
31
|
308
|
|
78815
|
PET IMAGE W/CT SKULL-THIGH |
30
|
30
|
|
71260
|
CT THORAX DX C+ |
29
|
29
|
|
96413
|
CHEMO IV INFUSION 1 HR |
29
|
29
|
|
96367
|
TX/PROPH/DG ADDL SEQ IV INF |
29
|
30
|
|
J9263
|
OXALIPLATIN |
28
|
4,228
|
|
J1930
|
LANREOTIDE INJECTION |
26
|
3,120
|
|
A9552
|
F18 FDG |
26
|
27
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C17.8 related to the following DRG Codes:
374-376
|
